Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' item and the older 'Revision: v3.3.2' entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:29:45.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 to the history and removed Revision: v3.2.0. This represents a minor UI/version update to the page.
    Difference
    0.1%
    Check dated 2025-11-24T21:18:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed the banner warning about government funding lapses and processing delays that previously appeared on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:43:54.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The old and new screenshots show the same Record History content with only minor visual/layout adjustments; no data, version entries, or study details appear to have changed.
    Difference
    0.1%
    Check dated 2025-11-03T13:11:51.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    9%
    Check dated 2025-10-05T17:41:29.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T11:18:52.000Z thumbnail image

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.